Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IonQ, Inc. (IONQ) filed a prospectus supplement registering the resale by selling stockholders of up to 13,220,367 shares of common stock. The company will receive no proceeds from these sales. As of August 5, 2025, there were 296,841,308 shares outstanding and the last reported NYSE sale price was $42.02 per share on August 5, 2025.
The supplement discloses detailed selling stockholder positions (including institutional holders such as SK Square and USIT Holdco), escrowed shares related to the ID Quantique acquisition (including 902,160 escrowed shares), and a specified director/officer lock-up period from July 7, 2025 through September 5, 2025. The filing reiterates the companys recent operating losses of $209.1 million and $77.2 million for the six months ended June 30, 2025 and 2024, respectively, and an accumulated deficit of $892.8 million as of June 30, 2025.
IonQ, Inc. filed a prospectus supplement to its Form S-3ASR registration statement (File No. 333-285279) covering the resale by certain selling stockholders of 13,220,367 shares of common stock. A legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP is filed as Exhibit 5.1 and the firm's consent is included as Exhibit 23.1. The filing also includes the cover page interactive data file as Exhibit 104. The prospectus supplement and attached opinion are incorporated by reference into the registration statement to register the resale of the specified shares.
Thomas G. Kramer, Chief Financial Officer of IonQ, Inc. reported the sale of 537,880 shares of common stock on 08/06/2025 pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. The reported weighted average sale price was $41.2804, with individual trades ranging from $40.88 to $43.00. Following these transactions, the reporting person beneficially owns 17,776 shares directly and 5 shares indirectly through a child.
The Form 4 discloses the sale activity and includes an undertaking to provide details on the number of shares sold at each price within the disclosed range upon request.
IonQ, Inc. (IONQ) – Form 4 filing dated 07/24/2025: Director Gabrielle B. Toledano received 3,696 restricted stock units (RSUs) on 07/23/2025. Each RSU converts into one share of common stock at no cost to the director.
Vesting schedule: One-third of the RSUs will vest on 02/24/2026 and on each of the next two annual anniversaries, provided Toledano continues serving on IonQ’s board.
Post-transaction holdings: Toledano now beneficially owns 10,001 common shares, held directly. No share sales or derivative transactions were reported.
The filing represents a routine equity grant meant to align the director’s incentives with shareholders; it has immaterial dilution and does not signal any change in IonQ’s operational or financial outlook.
IonQ, Inc. (NYSE: IONQ) filed a Form 8-K reporting that on 11 July 2025 it closed the previously announced acquisition of Capella Space Corp. Under the Agreement and Plan of Merger dated 7 May 2025, Capella merged with a wholly-owned IonQ subsidiary and now operates as the surviving corporation.
Transaction terms: Capella securityholders received 7,401,396 newly issued IonQ common shares (the “Stock Consideration”). The shares were issued privately under Section 4(a)(2) and Rule 506 of Regulation D, triggering Item 3.02 disclosure for an unregistered equity sale.
Registration Rights: A Registration Rights Agreement dated 11 July 2025 (filed as Exhibit 10.1) grants Capella securityholders standard demand and piggy-back rights to resell the Stock Consideration once registered.
Communication: IonQ released a press announcement on 15 July 2025 (furnished as Exhibit 99.1) confirming deal completion; the release is furnished under Item 7.01 and not deemed “filed.”
- Item 3.02: Unregistered issuance of 7.4 million shares.
- Item 7.01: Regulation FD press release.
- Item 8.01: Completion of Capella acquisition.
- Item 9.01: Exhibits 10.1 (Registration Rights), 99.1 (Press Release), 104 (Cover Page XBRL).
The all-stock structure avoids immediate cash outflow but dilutes existing shareholders. The filing provides no pro-forma financials or strategic metrics regarding Capella’s contribution.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
